The effects of β-alanine supplementation on muscle pH and the power-duration relationship during high-intensity exercise by Matt I. Black (7211009) et al.
ORIGINAL RESEARCH
published: 21 February 2018
doi: 10.3389/fphys.2018.00111
Frontiers in Physiology | www.frontiersin.org 1 February 2018 | Volume 9 | Article 111
Edited by:
Bruce M. Damon,
Vanderbilt University Medical Center,
United States
Reviewed by:
David Marcinek,
University of Washington,
United States
Scott Forbes,
Brandon University, Canada
Theodore Francis Towse,
Grand Valley State University,
United States
Sean Forbes,
University of Florida, United States
*Correspondence:
Matthew I. Black
mib204@exeter.ac.uk
Specialty section:
This article was submitted to
Exercise Physiology,
a section of the journal
Frontiers in Physiology
Received: 17 October 2017
Accepted: 05 February 2018
Published: 21 February 2018
Citation:
Black MI, Jones AM, Morgan PT,
Bailey SJ, Fulford J and Vanhatalo A
(2018) The Effects of β-Alanine
Supplementation on Muscle pH and
the Power-Duration Relationship
during High-Intensity Exercise.
Front. Physiol. 9:111.
doi: 10.3389/fphys.2018.00111
The Effects of β-Alanine
Supplementation on Muscle pH and
the Power-Duration Relationship
during High-Intensity Exercise
Matthew I. Black 1*, Andrew M. Jones 1, Paul T. Morgan 1, Stephen J. Bailey 2,
Jonathan Fulford 3 and Anni Vanhatalo 1
1 Sport and Health Sciences, College of Life and Environmental Sciences, University of Exeter, Exeter, United Kingdom,
2 School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, United Kingdom, 3NIHR Exeter
Clinical Research Facility, University of Exeter, Exeter, United Kingdom
Purpose: To investigate the influence of β-alanine (BA) supplementation on muscle
carnosine content, muscle pH and the power-duration relationship (i.e., critical power
and W′).
Methods: In a double-blind, randomized, placebo-controlled study, 20
recreationally-active males (22 ± 3 y, V˙O2peak 3.73 ± 0.44 L·min
−1) ingested either BA
(6.4 g/d for 28 d) or placebo (PL) (6.4 g/d) for 28 d. Subjects completed an incremental
test and two 3-min all-out tests separated by 1-min on a cycle ergometer pre- and
post-supplementation. Muscle pH was assessed using 31P-magnetic resonance
spectroscopy (MRS) during incremental (INC KEE) and intermittent knee-extension
exercise (INT KEE). Muscle carnosine content was determined using 1H-MRS.
Results: There were no differences in the change in muscle carnosine content from
pre- to post-intervention (PL: 1 ± 16% vs. BA: −4 ± 25%) or in muscle pH during INC
KEE or INT KEE (P > 0.05) between PL and BA, but blood pH (PL:−0.06± 0.10 vs. BA:
0.09 ± 0.13) during the incremental test was elevated post-supplementation in the BA
group only (P < 0.05). The changes from pre- to post-supplementation in critical power
(PL: −8 ± 18W vs. BA: −6 ± 17W) and W′ (PL: 1.8 ± 3.3 kJ vs. BA: 1.5 ± 1.7 kJ) were
not different between groups. No relationships were detected between muscle carnosine
content and indices of exercise performance.
Conclusions: BA supplementation had no significant effect on muscle carnosine
content and no influence on intramuscular pH during incremental or high-intensity
intermittent knee-extension exercise. The small increase in blood pH following BA
supplementation was not sufficient to significantly alter the power-duration relationship
or exercise performance.
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INTRODUCTION
The critical power (CP) model of high-intensity exercise
performance is defined by two parameters: the CP, representing
the highest sustainable rate of oxidative phosphorylation, and
the W′, notionally a fixed energy store derived principally from
substrate-level phosphorylation (Monod and Scherrer, 1965;
Moritani et al., 1981; Poole et al., 1988; Jones et al., 2008,
2010). Metabolic acidosis, which has been implicated in the
fatigue process (Fitts, 1994; Chin and Allen, 1998), develops
progressively during exercise >CP, with muscle and blood pH
attaining consistent and presumably critically low values at task
failure (Poole et al., 1988; Vanhatalo et al., 2010). Consistent
with the notion that metabolic acidosis contributes to muscular
fatigue, improved muscle H+ efflux is related to enhanced
intense exercise performance (Hostrup and Bangsbo, 2017).
Intramuscular H+ accumulation has been shown to interfere
with the release of Ca2+ from the sarcoplasmic reticulum and
thus impair excitation-contraction coupling (Knuth et al., 2006;
Debold et al., 2008), inhibit glycolysis (Gevers and Dowdle,
1963; Trivedi and Danforth, 1966; Spriet et al., 1987) and
slow PCr recovery following exercise (Harris et al., 1976). The
ability to attenuate the rate of muscle H+ accumulation during
exercise and/or enhance its removal from the muscle during
recovery may therefore reduce the extent of exercise-induced
disruption to excitation-contraction coupling, glycolytic flux,
and PCr recovery and permit increased performance during
continuous and intermittent high-intensity exercise.
Carnosine (β-alanyl-L-histidine) is a cytoplasmic dipeptide
found in high concentrations within skeletal muscle (Harris
et al., 2006), which, due to the pKa of its imidazole side-chain
(6.83), is a potent buffer for intramuscular H+ accumulation
during contractions (Bate-Smith, 1938). β-alanine (BA) has been
identified as the rate-limiting substrate in carnosine synthesis
(Dunnet and Harris, 1999; Harris et al., 2006) and its ingestion
has been shown to increase intramuscular carnosine content
(Harris et al., 2006; Baguet et al., 2009; Stellingwerff et al.,
2012; Stegen et al., 2013, 2014; Bex et al., 2014) which would
presumably improve intramuscular buffering capacity. Some
investigations have reported improved high-intensity exercise
tolerance and performance following BA supplementation
(Hobson et al., 2012; Quesnele et al., 2014; Saunders et al.,
2017). However, other studies have shown no significant effect
of BA supplementation on performance (Sweeney et al., 2010;
Saunders et al., 2012a; Ducker et al., 2013; Jagim et al.,
2013), despite subjects following an appropriate supplementation
strategy (Hobson et al., 2012) and completing a test ostensibly
>CP that would be expected to result in a large decline in muscle
pH (Bogdanis et al., 1998; Vanhatalo et al., 2016). Furthermore,
despite possible ergogenic effects of BA supplementation being
attributed to enhanced intramuscular buffering capacity, no
study has assessed differences in muscle pH during exercise in
humans following BA supplementation. 31P-MRS affords the
opportunity to non-invasively assess muscle pH during exercise
with a high temporal resolution.
Given that the W′ has been proposed to represent a work
capacity comprising the energy available from the “anaerobic”
energy pathways (Moritani et al., 1981; Miura et al., 1999, 2000),
it would be expected that an increased glycolytic flux during
exercise >CP would increase W′. Attenuating the decline in
muscle pHmay delay the attainment of a “critical” intramuscular
milieu which is associated with the complete utilization of the
W′ (Vanhatalo et al., 2010), and thus should be reflected by an
increased W′. Enhanced muscle buffering may also expedite the
restoration of muscular homeostasis following exercise >CP by
permitting enhanced PCr recovery and improving glycolytic flux
during a subsequent>CP exercise bout. Improved intramuscular
buffering capacity may therefore enhance exercise performance
>CP through enhanced W′ and improved W′ recovery kinetics
(Skiba et al., 2015).
The purpose of this study was to evaluate the physiological and
performance effects of 4 weeks of BA supplementation (6.4 g·d−1)
on muscle carnosine, muscle pH and the power-duration
relationship. It was hypothesized that BA supplementation
would: (1) increase the muscle carnosine content at rest; (2)
increase intramuscular pH and improve performance during
high-intensity, intermittent knee-extension exercise; and (3)
increase the size of the W′ estimated in a 3-min all-out
cycling test and improve all-out and ramp incremental cycling
performance.
METHODS
Subjects
Twenty healthy male subjects (mean ± SD: age 22 ± 3 y, height
1.77± 0.07m, mass 79.0± 14.4 kg) volunteered to participate in
this study. Prior to testing, subjects were informed of the protocol
and possible risks of participation and, subsequently, provided
written consent to participate. All procedures were approved by
the local Research Ethics Committee and conformed to the code
of ethics of the Declaration of Helsinki.
Experimental Design
Subjects visited the laboratory on 5 occasions over a 2-week
period pre-supplementation, and on 6 occasions over a 2-
week period post-supplementation. Prior to supplementation,
baseline muscle carnosine content was determined using
1H magnetic resonance spectroscopy (1H-MRS) which was
followed by incremental knee extension exercise (INC KEE)
with muscle metabolic changes assessed via 31P magnetic
resonance spectroscopy (31P-MRS). During another visit,
subjects performed a ramp incremental cycling test for the
determination of the gas exchange threshold (GET) and V˙O2peak.
On a separate visit, subjects were familiarized to a “repeated
3-min all-out” protocol, which involved the performance of
two 3-min all-out tests (described in Burnley et al., 2006;
Vanhatalo et al., 2007) separated by 1min of passive recovery.
Subjects returned to the laboratory on a separate occasion
to complete an experimental repeated 3-min all-out test. On
another occasion, subjects performed an intermittent knee
extension exercise protocol (INT KEE) with metabolic changes
assessed via 31P-MRS. The order of tests was randomized except
that: familiarization to the repeated 3-min all-out test preceded
the experimental test; and, to set the appropriate work rates,
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the ramp incremental cycling test and INC KEE preceded the
repeated 3-min all-out test and INT KEE, respectively.
In a double-blind, placebo-controlled design, subjects
were assigned to BA (SR Carnosyn R©, Natural Alternative
International, San Marcos CA; sustained release 800mg tablets
e.g., Hill et al., 2007; Smith-Ryan et al., 2012) or a cornflower
placebo (PL) group (capsule). Groups were matched for physical
characteristics (age, body mass, height), baseline carnosine
content, and physiological/fitness measures (V˙O2peak, GET, CP,
W′). Subjects consumed 8 tablets/capsules per day of PL or BA,
including two tablets/capsules with every meal (breakfast, lunch,
dinner) and two tablets/capsules before bed such that the BA
dose was 6.4 g·d−1. Following 4 weeks of supplementation, each
subject reported to the laboratory to begin post-supplementation
tests. Subjects were instructed to continue their supplementation
regime during the post-supplementation visits, and therefore
supplemented their diet for a total of 6 weeks. The post-
supplementation visits comprised the same exercise tests and
were performed in the same order as the pre-supplementation
visits, with an additional carnosine scan following the completion
of all visits after ∼6 weeks of supplementation. Subjects were
instructed to follow their normal dietary and exercise habits
throughout the study. Experimental visits were scheduled at the
same time of day (±3 h) and subjects were instructed to report
to all testing sessions in a rested and well-hydrated state, having
avoided strenuous exercise for 24 h and caffeine for 3 h prior to
each test.
Exercise Tests
All cycling tests were performed on the same electronically-
braked ergometer (Lode Excalibur Sport, Groningen, The
Netherlands). The ergometer seat and handlebars were adjusted
for comfort, and settings were recorded and replicated for
subsequent visits. The ramp incremental protocol consisted of
3min of unloaded baseline pedaling followed by a ramp increase
in power output of 30W.min−1 until task failure. Subjects
were instructed to maintain their self-selected cadence (80 rpm,
n= 18; 85 rpm, n= 1; 90 rpm, n= 1) for as long as possible. The
test was terminated when the pedal rate fell >10 rpm below the
chosen cadence for >5 s despite strong verbal encouragement.
V˙O2peak was determined as the highest 30-smean value. The GET
was established from the gas exchange data averaged in 10-s time
bins using the following criteria: (1) the first disproportionate
increase in V˙CO2 vs. V˙O2; (2) an increase in minute ventilation
(V˙E) relative to V˙O2 with no increase in V˙E/V˙CO2; and (3) the
first increase in end-tidal O2 tension with no fall in end-tidal CO2
tension.
The repeated 3-min all-out test began with 3min of baseline
pedaling (20W), at the same self-selected cadence chosen during
the ramp incremental test, followed by two 3-min all-out efforts
separated by 1min of active recovery (20-W cycling). Subjects
were asked to accelerate to 110–120 rpm over the final 5 s of
the baseline period, and for the final 5 s of the active recovery.
The resistance on the pedals during the 3-min all-out test was set
using the linear mode of the ergometer such that, on reaching
their preferred cadence, the power output would be equivalent
to 50% of the difference between the power output at GET and
V˙O2peak (linear factor = power/cadence
2). To ensure an all-out
effort, subjects were instructed and strongly encouraged to attain
their peak power output as quickly as possible, and to maintain
their cadence as high as possible until instructed to stop. CP was
estimated as the mean power output during the final 30 s of bout
1. End test power (EP) was determined as the mean 30 s power
output during the final 30 s of bout 2. Bout 1 W′ was defined
as the amount of work done above bout 1 CP. During bout 2,
the amount of work performed above bout 1 CP (W > CP), was
determined to provide a measure of W′ recovery. The V˙O2peak
during each bout of the repeated 3-min all-out test was calculated
as the highest 15 s rolling mean value.
To assess muscle metabolism during exercise, subjects
performed single-legged knee-extension exercise in a prone
position within a magnetic resonance scanner, as described by
Vanhatalo et al. (2010). The INC KEE consisted of 30 s of exercise
lifting 1 kg, followed by a 0.5 kg increase in mass every 30 s until
task failure. For the INT KEE exercise protocol, the weight within
the load basket was 120% of the peak work rate recorded in
the ramp incremental test with the protocol consisting of 60 s
of high-intensity work, followed by 18 s of passive rest, with the
sequence repeated until task failure.
Pulmonary Gas Exchange
Breath-by-breath pulmonary gas exchange data were collected
continuously during all cycling tests, with subjects wearing a
nose clip and breathing through a low-dead space, low resistance
mouthpiece and impeller turbine assembly (Triple V, Jaeger,
Hoechberg, Germany). The inspired and expired gas volume
and gas concentration signals were sampled continuously at
100Hz, the latter using paramagnetic (O2) and infrared (CO2)
analysers (Oxycon Pro, Jaeger) via a capillary line connected
to the mouthpiece. These analysers were calibrated before each
test with gases of known concentration, and the turbine volume
transducer was calibrated using a 3-L syringe (Hans Rudolph,
KS). The volume and concentration signals were time-aligned,
accounting for the transit delay in capillary gas and analyser rise
time relative to the volume signal. The V˙O2, V˙CO2 and V˙E were
calculated for each breath using standard formulae.
Blood Analyses
Venous blood samples were drawn into 5-mL lithium heparin
tubes (Terumo Corporation, Leuven, Belgium) at baseline and
at discrete time-points during the 3-min all-out test (bout
1 and 2: 30, 60, 90, 170, and 30 s post-test) and the ramp
incremental test (120, 240, 360, 480, 600 s, Tlim, Tlim +60 s,
Tlim +120 s) from a cannula (Insyte-W
TM, Becton-Dickinson,
Madrid, Spain) inserted into the subject’s antecubital vein. The
blood was analyzed for lactate concentration ([La]) (YSI 2300,
Yellow Springs Instruments, Yellow Springs, OH) and 1.5mL of
whole blood was extracted and stored at −80◦C for subsequent
determination of pH.
MRS Measurements
MRS measurements were performed within the bore of a 1.5 T
superconducting magnet (Gyroscan Clinical Intera, Philips, The
Netherlands). Muscle carnosine content was measured in the
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vastus medialis (VM), vastus lateralis (VL), and rectus femoris
(RF) muscles using 1H-MRS. Subjects were secured to the
scanner bed in the supine position via Velcro straps which were
fastened across the thigh to minimize movement during the
scans. Following the acquisition of a localiser series, a high-
resolution coronal imaging series of the thigh was acquired to
allow identification of the lateral and medial condyles (Fast spin
echo, echo train 19, repetition time of 2,660ms, echo time of
13ms, slice 4mm, pixel 0.625× 0.625mm). A location within the
center of the thigh was selected from the coronal images relative
to the condyles using measurement tools contained within the
scanner software. A transverse image was then acquired at this
location (fast spin echo repetition time of 115ms, echo time of
15ms, slice thickness 4mm, pixel 0.98 × 0.98mm) and used for
the placement of the MRS voxels (20 [anterior-posterior) × 30
(right-left)× 50 (foot-head) mm for individual muscles, 30× 70
× 50mm for voxel centered over the quadriceps). Single-voxel
point resolved spectroscopy was undertaken with a 4-element
flexible surface coil (45 cm diameter right-left, 30 cm diameter
foot-head) with the following parameters: repetition time of
2,000ms, echo time of 30ms, 128 excitations, 1,024 data points,
spectral bandwidth of 1,200Hz, and a total acquisition time of
4.24min. The sequence included a range of preparation phases,
including the determination of the water resonance frequency,
90 degree pulse power calibration, shimming and gradient
adjustments. For the repeat visits, scout and coronal images were
again acquired and the transverse slice position replicated by
placing the slice at the same distance from the condyles as for
the baseline visit. The integral of the carnosine-H2 peak [at ∼8
parts per million (ppm)] was quantified relative to the water
peak integral (×1,000) using the AMARES fitting algorithm in
the jMRUI (version 3) software package (http://www.mrui.uab.
cat/mrui). Muscle [carnosine] was expressed as a ratio relative to
the water peak. To determine the reliability of this assessment, a
separate cohort of 6 subjects visited the laboratory on consecutive
days for the determination of baseline muscle carnosine content.
Subjects were instructed to arrive at the laboratory well-hydrated
and rested, having avoided strenuous exercise for 24 h prior to
the assessment. Each scan was performed at the same time of day
(±2 h) for each individual.
Concentrations of phosphorous-containing muscle
metabolites and pH during exercise were determined as
previously described (Vanhatalo et al., 2010). Briefly, a 6 cm 31P
transmit/receive surface coil was placed within the ergometer
bed, and the subject was positioned so that the coil was centered
over the quadriceps muscle of the right leg. Initially, fast field
echo images were acquired to determine the correct positioning
of the muscle in relation to the coil. A number of pre-acquisition
steps were performed to optimize the signal from the muscle
under investigation, and tuning and matching of the coil were
performed to maximize energy transfer between the coil and the
muscle. To ensure that the muscle was consistently at the same
distance from the coil at the time of data sampling, the subjects
matched their movement (i.e., extension and flexion of the knee)
to an audible cue. Data were acquired every 1.5 s with a spectral
width of 1,500Hz and 1,000 data points. Phase cycling with four
phase cycles was employed, leading to a spectrum being acquired
every 6 s. Intracellular pH was calculated using the chemical shift
of the Pi spectra relative to the PCr peak (Taylor et al., 1983). The
[PCr] and [Pi] were expressed as percentage change relative to
resting baseline, which was assumed to represent 100%. Resting
and end-exercise values of [PCr], [Pi], and pH were calculated
over the last 30 s of the rest or exercise period.
Statistical Analyses
Independent samples t-tests were used to assess differences
between the groups prior to supplementation. Analysis of
variance (ANOVA) with repeated measures was used to test for
differences in V˙O2peak between the ramp incremental cycling
test and bout 1 and 2 of the repeated 3-min all-out cycling
test. A repeated measures analysis of covariance (ANCOVA),
with baseline values used as the covariate, was used to test
for differences between supplementation groups in the ramp
incremental test (V˙O2peak, GET, peak power output, blood pH
and [La]), the repeated 3-min all-out test (CP, EP, W′, W>CP,
peak power output, total work done (TWD), blood pH and [La]),
the incremental- and intermittent knee extension exercise tests
(muscle pH, [Pi] and [PCr]), and muscle carnosine content.
All significant main and interaction effects were followed up
using Fisher’s least significant difference post hoc tests. The
coefficient of variation (CV %) was used to assess the day-to-
day variability in determination of muscle carnosine content.
Pearson’s product-moment correlation coefficients were used to
assess the association between muscle carnosine content and
performance. All data are presented as mean ± SD. Statistical
analysis was performed using SPSS version 22 (SPSS Inc.,
Chicago, Illinois, USA) with significance set as P < 0.05.
RESULTS
There were no significant differences in physical characteristics
or physiological/fitness measures at baseline between the
PL and BA supplementation groups (Table 1). No subject
TABLE 1 | Group mean (± SD) baseline physical characteristics and physiological
responses to the ramp incremental cycling test, bout 1 of the repeated 3-min
all-out cycling test, and whole thigh muscle carnosine content for the placebo (PL)
and β-alanine (BA) groups.
PL BA
PHYSICAL CHARACTERISTICS
Mass (kg) 81.0 ± 18.1 77.1 ± 10.0
Age (y) 21 ± 3 23 ± 4
PHYSIOLOGICAL CHARACTERISTICS
Ramp test V˙O2peak (L·min
−1) 3.81 ± 0.52 3.64 ± 0.28
Ramp test peak power (W) 350 ± 49 344 ± 30
GET (W) 125 ± 15 115 ± 16
CP (W) 236 ± 47 232 ± 32
W′ (kJ) 17.8 ± 5.6 18.5 ± 1.8
Muscle carnosine (whole thigh) (A.U.) 0.228 ± 0.132 0.203 ± 0.082
The post-supplementation whole thigh muscle carnosine values are presented as the
mean of the two post-supplementation scans at 4 and 6 weeks. No significant differences
were observed between the groups (P > 0.05).
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reported any adverse effects of supplementation, and self-report
supplementation diaries, which were issued weekly, confirmed
adherence to the supplementation regimen. Eleven subjects
correctly identified the supplementation group to which they
were assigned (BA, n= 6; PL, n= 5).
Muscle Carnosine Content
BA supplementation did not significantly increase muscle
carnosine content following 4 weeks of supplementation in the
VM (Week 0, 0.183 ± 0.051 vs. Weeks 4, 0.137 ± 0.053), VL
(Week 0, 0.207± 0.074 vs. Weeks 4, 0.223± 0.098), RF (Week 0,
0.145 ± 0.116 vs. Weeks 4, 0.151 ± 0.072), or across the whole
thigh (Week 0, 0.203 ± 0.082 vs. Weeks 4, 0.194 ± 0.083;
Figure 1). Similarly, muscle carnosine content was not significant
increased from baseline in the VM (0.164 ± 0.049), VL (0.211
± 0.086), RF (0.147 ± 0.068), or across the whole thigh (0.186
± 0.076) following 6 weeks of supplementation (Figure 1). No
significant differences inmuscle carnosine content were observed
FIGURE 1 | A representative 1H-MRS spectrum is provided in (A). The muscle carnosine content for the placebo (white) and β-alanine (gray) groups for the whole
quadriceps (B), rectus femoris (C), vastus lateralis (D), and vastus medialis (E). Solid lines indicate individual responses in muscle carnosine content. For clarity, error
bars were omitted.
Frontiers in Physiology | www.frontiersin.org 5 February 2018 | Volume 9 | Article 111
Black et al. Muscle pH and the Power-Duration Relationship
following 4 and 6 weeks of supplementation (Figure 1). The
day-to-day variability (CV %) in the assessment of baseline
muscle carnosine content by 1H-MRS was 15 ± 8% (range:
3% to 26%). The variability in the assessment of carnosine in
the placebo group between baseline and following 4 weeks of
supplementation was 15± 13% (range: 0–51%), 18± 16% (range:
0–74%) following 6 weeks of supplementation, and 18 ± 16%
(range: 0–76%) between weeks 4 and 6.
Muscle and Blood pH
No differences were observed in muscle pH between the
supplementation groups (BA vs. PL), at rest, at Tlim, or at any
time-point during INC KEE or INT KEE (Figure 2). No between
group changes were observed in muscle [Pi] and [PCr] during
INT KEE and INC KEE (P > 0.05) (Table 2).
The BA group had a greater blood pH post supplementation
compared to the PL group at discrete time-points during ramp
incremental cycling (P < 0.05) (Figure 3). Blood [La] was
significantly greater in the BA group following 480 s of ramp
incremental cycling (P < 0.05), and remained significantly
elevated at exhaustion (P < 0.05) (Figure 3). There were no
significant between group differences in blood pH or [La]
at any time-point during the repeated 3-min all-out test
(P > 0.05).
Power-Duration Relationship
The group mean power profiles for both bouts of the repeated
3-min all-out test are displayed in Figure 4. The V˙O2peak
values attained during bout 1 (Pre: 3.90 ± 0.52 L.min−1; Post:
3.75± 0.48 L.min−1) and bout 2 (Pre: 3.97± 0.40 L.min−1; Post:
3.79 ± 0.47 L.min−1) of the repeated 3-min all test were not
significantly different from V˙O2peak (Pre: 3.82 ± 0.41 L.min
−1;
Post: 3.68± 0.41 L.min−1) achieved during the ramp incremental
test (P > 0.05). There were no significant between group
differences for V˙O2peak, CP or EP, W
′ orW> CP, TWD and peak
power output following supplementation (P > 0.05) (Table 3;
FIGURE 2 | The placebo (PL; white) and β-alanine (BA; gray) group mean muscle pH response during incremental (INC KEE) (A,B) and intermittent (INT KEE) (C,D)
knee-extension exercise pre- (circles) and post- (triangles) supplementation. Error bars represent SD. For clarity, error bars are omitted for all data points except Tlim.
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TABLE 2 | Muscle phosphocreatine ([PCr]) and inorganic phosphate ([Pi]) concentrations and pH at Tlim during incremental (INC KEE) and intermittent (INT KEE) knee
extension exercise pre- and post-supplementation for the placebo (PL) and β-alanine (BA) groups.
INC KEE INT KEE
PL BA PL BA
Pre Post Pre Post Pre Post Pre Post
End-exercise [PCr] (%) 53 ± 13 52 ± 9 52 ± 9 51 ± 10 49 ± 9 47 ± 12 40 ± 8 44 ± 10
End-exercise [Pi] (%) 442 ± 132 412 ± 73 418 ± 105 431 ± 91 422 ± 84 414 ± 110 510 ± 134 469 ± 58
Baseline pH 7.03 ± 0.02 7.04 ± 0.04 7.05 ± 0.03 7.05 ± 0.01 7.04 ± 0.02 7.04 ± 0.02 7.04 ± 0.01 7.05 ± 0.02
End-exercise pH 6.77 ± 0.20 6.82 ± 0.14 6.88 ± 0.07 6.84 ± 0.12 6.65 ± 0.23 6.57 ± 0.25 6.29 ± 0.15 6.33 ± 0.23
1pH −0.26 ± 0.20 −0.22 ± 0.15 −0.14 ± 0.03 −0.19 ± 0.12 −0.38 ± 0.24 −0.46 ± 0.24 −0.75 ± 0.16 −0.72 ± 0.24
[PCr] and [Pi] are expressed relative to resting baseline.
FIGURE 3 | The placebo (white) and β-alanine (gray) group mean blood pH (A,B) and blood lactate ([La]) (C,D), during the pre- (circles) and post-supplementation
(triangles) ramp incremental test. Significant between group differences are denoted by *P < 0.05. Error bars represent SD.
Figure 5). No significant correlations were observed between
the absolute or percentage change in whole muscle carnosine
content or the blood [La] or blood [pH], and the absolute or
percentage change in CP, W′, TWD, or peak power output (all
P > 0.05).
Ramp Incremental Cycling Test
Performance
There was a significant between group difference for peak power
output (P < 0.05), which was greater in the BA group from pre-
to post-supplementation (1: 7 ± 10W), relative to the PL group
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FIGURE 4 | The group mean power profiles during the repeated 3-min all-out
test for placebo (PL; A) and β-alanine (BA; B) groups pre- (circles) and post-
(triangles) supplementation. The data are shown every 10 s. SD is displayed by
negative error bars for the pre-, and positive error bars for the
post-supplementation trials.
(1: −5 ± 13W) (Figure 5). No between group differences were
observed for the GET estimated in the ramp incremental test
(P > 0.05) (Figure 5).
Knee-Extension Exercise Performance
There was no significant between group difference for INC KEE
or INT KEE performance following supplementation (P > 0.05)
(Figure 6).
DISCUSSION
We employed a comprehensive exercise testing regimen, which
included whole-body and single-legged exercise modalities and
the use of 1H- and 31P-magnetic resonance spectroscopy to
determine muscle carnosine content and muscle metabolic
changes during exercise, respectively, to investigate the influence
TABLE 3 | Group mean (± SD) critical power (CP), W′, total work done (TWD),
end test power (EP) and work done above CP (W > CP) determined during bout 1
and 2 of the 3-min all-out test pre- and post-supplementation.
PL BA
Pre Post Pre Post
Bout 1 CP (W) 236 ± 47 229 ± 52 232 ± 32 226 ± 38
W′ (kJ) 17.8 ± 5.6 19.5 ± 3.6 18.5 ± 1.8 20.0 ± 1.6
TWD (kJ) 60.3 ± 8.6 60.7 ± 9.1 60.2 ± 6.4 60.6 ± 7.4
Peak power
output (W)
858 ± 184 930 ± 162 960 ± 137 946 ± 100
Bout 2 EP (W) 226 ± 52 210 ± 51 222 ± 25 211 ± 31
W > CP (kJ) 5.6 ± 2.7 4.0 ± 4.0 5.0 ± 2.4 4.3 ± 3.2
TWD (kJ) 48.1 ± 9.6 45.2 ± 9.2 46.7 ± 5.3 44.9 ± 6.2
Peak power
output (W)
741 ± 190 732 ± 163 700 ± 74 741 ± 125
No significant interaction effects (group × time) were observed.
of BA supplementation on exercise performance. The principal
findings of this study were that BA supplementation did
not significantly increase muscle carnosine content or alter
intramuscular pH or performance during incremental or
intermittent knee-extension exercise, or alter the power-
duration relationship during all-out cycling. However, BA
supplementation attenuated the fall in blood pH and improved
performance by 2 ± 3% during ramp incremental cycle exercise.
Although there was great inter-individual variability in muscle
carnosine responses to BA supplementation, no relationships
were observed between muscle carnosine content and blood pH
or exercise performance.
The findings of the current study indicate that muscle
carnosine content was not increased following 4 and 6 weeks
of BA ingestion (6.4 g·d−1). This is in contrast to previous
studies that have assessed muscle carnosine content using 1H-
MRS and have shown that BA supplementation results in
increased carnosine content in muscles of the calf (Baguet
et al., 2009, 2010; del Favero et al., 2012; Stegen et al., 2013,
2014; Bex et al., 2014; Danaher et al., 2014; Hoffman et al.,
2015), thigh (Harris et al., 2006), and upper arm and shoulder
(Bex et al., 2014). Whilst these studies employed a variety
of different supplementation strategies, and although baseline
muscle carnosine content and loading rates appear to be muscle
specific (Baguet et al., 2009, 2010; Stegen et al., 2013, 2014;
Bex et al., 2014; Danaher et al., 2014), they have consistently
reported ∼45% increase in muscle carnosine following a total
BA dose of ∼181 g during the supplementation period. In the
present study, subjects had ingested a total of 179 g BA after
4 weeks and 269 g BA after 6 weeks. Given the large increases
in muscle carnosine content reported previously, our method
should have been sufficiently sensitive (CV ∼15%) to detect
changes between groups following BA supplementation. A large
inter-individual variability was observed in the relative change
in muscle carnosine content in response to BA supplementation
(−51 to 31%). This finding is similar to Hill et al. (2007) and
Baguet et al. (2009) who reported a range of −1 to 161% and 2
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FIGURE 5 | The placebo (PL; white) and β-alanine (BA; gray) group mean and individual critical power (CP; A) and W′ (B) determined during the 3-min all-out test,
and power output at GET (C) and peak power output (PPO) (D) determined during the ramp incremental test. Pre- and post-supplementation data are presented as
circles and triangles, respectively. Significant interaction effects are denoted by *P < 0.05.
to 69%, respectively. Whilst a greater baseline carnosine content
has been observed in human type II muscle fibers (Suzuki et al.,
2002; Hill et al., 2007), both type I and type II muscle phenotypes
have been shown to respond equally well to BA supplementation
(Hill et al., 2007; Baguet et al., 2009). Therefore, individual
differences in muscle fiber type composition are unlikely to
explain inter-individual variation in muscle carnosine response
to BA supplementation. The training status of the muscle may
influence the magnitude of increase in carnosine, with a greater
relative increase reported inmore highly exercisedmuscle groups
following BA supplementation, possibly due to a greater delivery
of BA to the muscle mediated by an increased blood flow
and increased capillary density, and/or a contraction induced
stimulation of taurine (TauT) and H+/amino acid 1 (PAT1)
transporters which facilitate BA uptake into the myocyte (Bex
et al., 2014). Given that the subjects in the current study were
matched at baseline, were not trained in any particular sport,
and that there was no association between muscle carnosine
increase and parameters of fitness (i.e., V˙O2peak, GET, CP, W
′),
it is unlikely that these factors can explain the inter-individual
differences in muscle carnosine responses we observed. It has
been shown that L-histidine concentrations decrease by∼27 and
∼31% relative to baseline following 12 and 23 days of 6 g·d−1
BA supplementation, respectively (Blancquaert et al., 2017). It is
possible that reduced L-histidine bioavailability at baseline and
as a consequence of BA supplementation may, in part, explain
differences in muscle carnosine responses between subjects in
the current study and in previous research (Harris et al., 2006;
Baguet et al., 2009; Stellingwerff et al., 2012; Stegen et al., 2013,
2014; Bex et al., 2014). A novel finding of our study is that
4–6 weeks of BA supplementation may not always result in a
measurable increase in muscle carnosine content (cf. Hill et al.,
2007). The factors regulating muscle carnosine content require
further research.
The ergogenic effect of BA supplementation has been
primarily attributed to its role in the synthesis of muscle
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FIGURE 6 | The placebo (PL; white) and β-alanine (BA; gray) group mean and individual Tlim during incremental (INC KEE) (A,B) and intermittent (INT KEE) (C,D)
knee-extension exercise pre- (circles) and post- (triangles) supplementation.
carnosine, a potent intramuscular pH buffer (Bate-Smith, 1938).
However, to our knowledge there has only been one study that
has previously assessed muscle buffering capacity in humans
following BA supplementation and, despite observing an increase
in muscle carnosine, found no improvements in muscle buffering
capacity (Gross et al., 2014). In the current study, we used 31P-
MRS to assess muscle pH during single-legged knee-extension
exercise. It was shown that BA supplementation did not result in
changes in muscle pH at rest or during INC KEE or INT KEE
and no performance improvement was observed. In addition
to INT KEE, we used a repeated 3-min all-out cycling test to
determine whether BA supplementation might improve recovery
from intense whole-body exercise. The second bout of the 3-
min all out test was used to determine the amount of work
that could be performed above CP (W > CP) and thus served
as an index of W′ recovery. In agreement with Saunders et al.
(2012a), but in contrast with Saunders et al. (2012b) who studied
the effects of BA supplementation on intermittent exercise,
recovery following sprint exercise was not improved in the
present study. This observation is consistent with there being no
significant change in muscle carnosine content and no change
in muscle pH or performance during INT KEE following BA
supplementation.
There was a small but possibly meaningful change in blood
pH and performance during the ramp incremental cycling test
following BA supplementation, despite no significant change in
muscle carnosine content. However, it is important to point out
that the mean increase of ∼2% in ramp test peak power in the
BA group is similar in magnitude to coefficients of variation
shown for ramp test peak power across 4–6 weeks of placebo
supplementation (2.5 %, present study) and 4–5 weeks with
no dietary or exercise intervention (1.1%; Lindsay et al., 1996).
The increased blood pH and ramp test performance are in
contrast with previous studies that have shown no significant
improvements in incremental test performance following BA
supplementation (Zoeller et al., 2007; Van Thienen et al., 2009),
and the present finding that BA supplementation did not alter
the power-duration relationship or blood pH during the 3-
min all-out test. The CP and W′, when estimated using a
conventional protocol of multiple prediction trials, have also
been shown to be unaffected by BA supplementation (Smith-
Ryan et al., 2012). The 3-min all-out test has been shown to be
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sensitive to detect changes in the power-duration relationship
following training (Vanhatalo et al., 2008b) and acute normobaric
hypoxia (Simpson et al., 2015), but no effects on CP or W′
were found following sodium bicarbonate ingestion, despite
an elevated blood pH (Vanhatalo et al., 2010). Therefore,
dietary interventions that may transiently enhance muscle
(present study; Smith-Ryan et al., 2012) or blood (Vanhatalo
et al., 2010) buffering capacity in some individuals do not
appear to result in significant changes to the power-duration
relationship.
The effects of BA supplementation on high-intensity exercise
performance are equivocal (meta-analysis see Hobson et al.,
2012; Saunders et al., 2017), with improved exercise performance
having been reported by some (e.g., Saunders et al., 2012b;
Hoffman et al., 2015) but not all (e.g., Sweeney et al., 2010;
Saunders et al., 2012a; Ducker et al., 2013; Jagim et al., 2013)
previous studies. The discrepancy between findings does not
appear consistently linked to differences in supplementation
regimes or exercise test protocols. Ducker et al. (2013) and
Jagim et al. (2013) observed no effect of BA supplementation
despite following the same supplementation regime (6.0 g·d−1
for 4 weeks) as Hoffman et al. (2015). The repeated performance
of short sprint-intervals (Sweeney et al., 2010; Saunders et al.,
2012a; Ducker et al., 2013) or high-intensity constant work-
rate protocols (Jagim et al., 2013), which result in task
failure in ∼1–2.5min, would be expected to require substantial
contributions from glycolysis and thus to decrease muscle pH
(Bogdanis et al., 1995, 1998; Vanhatalo et al., 2016). Test duration
and supplementation strategy is therefore unlikely to explain
the lack of differences observed during the knee-extension
protocols, the power-duration relationship, and W > CP in the
current study. Although interpretation of the studies reporting
no significant improvements following BA supplementation
is limited due to the omission of a carnosine assessment
(Sweeney et al., 2010; Saunders et al., 2012a; Ducker et al.,
2013; Jagim et al., 2013), it seems reasonable to suggest
that BA supplementation may not have sufficiently increased
muscle carnosine content in most individuals within these
studies.
Experimental Considerations
It was not possible to assess muscle carnosine content on every
laboratory visit due to the large number of tests. It is possible
that a temporal lag of 3–4 days between some performance test
visits and muscle carnosine scans influenced the accuracy of
correlations between muscle carnosine and exercise performance
indices. Previous research has shown, however, that muscle
carnosine content is relative stable and has a slow wash-out rate
following BA supplementation (Stellingwerff et al., 2012). There
was no significant difference in muscle carnosine between 4 and
6 weeks of BA supplementation in the present study, although
some individual variability was evident (Figure 1). It may be
speculated that muscle carnosine content was elevated in the
majority of the subjects in the BA group at the time of the
ramp incremental test but not at the time of the 3-min all-out
tests. This seems unlikely, however, and the randomization of
exercise tests would have minimized any consistent order effect.
It should be considered that there are substantial differences in
the dynamics of muscle activation, glycolytic rate, muscle H+
efflux, blood flow and the rate of W′ utilization between the
ramp incremental and 3-min all-out sprint test protocols. These
differences might have contributed to the small performance
benefit observed in the ramp test but not the all-out sprint
test.
We assessed muscle carnosine in a 1.5 T scanner by
quantifying the integral of the carnosine peak relative to the
integral of the water peak, which enabled assessment of relative
changes in muscle carnosine from pre- to post-supplementation.
It should be noted, that all previous studies using 1H-MRS
to assess muscle carnosine content have used a 3.0 T scanner,
which would improve the signal-to-noise ratio. In the present
study, the CV % between baseline scans was similar when
performed on consecutive days (15 ± 8%) compared to scans
separated by 2 weeks (i.e., week 4 and 6 of supplementation;
18 ± 16%), 4 weeks (15 ± 13%), and 6 weeks (18 ± 16%).
We can therefore be confident that: (1) the technique we used
would have been sufficiently sensitive to detect the changes in
muscle carnosine that have been reported previously (Harris
et al., 2006; Baguet et al., 2009, 2010; del Favero et al., 2012;
Stegen et al., 2013, 2014; Bex et al., 2014; Danaher et al., 2014;
Hoffman et al., 2015); and (2) we did not observe an increase
greater than the measurement error. In keeping with the lack of
change observed in muscle carnosine content and thus buffering
capacity, we found no differences in muscle pH during INC
and INT KEE. Collectively, these findings strongly suggest that
the supplementation regime did not successfully increase muscle
carnosine content and muscle buffering capacity. Given that
adherence to the supplementation regime was confirmed by each
subject, it should also be considered that the supplement did
not contain the expected dosage of BA. The possible absence
of active ingredients in some commercially-available dietary
supplements has been noted as a concern previously (Maughan,
2013). However, given that the supplementation product used in
this study had been tested to ensure that it contains the identity
and quantity of ingredients indicated on the label (NSF Certified
for Sport), supplement contamination, and decreased presence
or omission of the active ingredient seems unlikely. Why we
did not observe a significant increase in muscle carnosine
and thus muscle buffering capacity having used a certified
supplement, followed an adequate BA loading strategy, and
utilized a sufficiently sensitive method for carnosine detection,
is unclear.
CONCLUSIONS
A variety of high-intensity exercise tests comprising different
work-rate forcing functions and exercise modalities were used to
assess possible ergogenic effects of BA supplementation. Under
the conditions of the present study, BA supplementation had a
variable and non-significant effect on muscle carnosine content
and no influence on intramuscular pH during high-intensity
incremental or intermittent knee-extension exercise. The small
increase in blood pH during ramp incremental cycle exercise
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following BA supplementation was associated with a small but
significantly greater increase in performance relative to the PL
group but this was not sufficient to alter the power-duration
relationship. Our findings indicate that BA supplementation may
not always increase muscle carnosine content, and clearly, in
such circumstances, no effect on exercise performance would be
expected.
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